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Abstract
Background: Each year an estimated 390 million dengue infections occur worldwide. In Malaysia, dengue is a
growing public health concern but estimate of its disease burden remains uncertain. We compared the urban-rural
difference of dengue seroprevalence and determined age-specific dengue seroprevalence in Malaysia.
Methods: We undertook analysis on 11,821 subjects from six seroprevalence surveys conducted in Malaysia
between 2001 and 2013, which composed of five urban and two rural series.
Results: Prevalence of dengue increased with age in both urban and rural locations in Malaysia, which exceeded
90 % among those aged 70 years or beyond. The age-specific rates of the 5 urban surveys overlapped without
clear separation among them, while prevalence was lower in younger subjects in rural series than in urban series,
the trend reversed in older subjects. There were no differences in the seroprevalence by gender, ethnicity or region.
Poisson regression model confirmed the prevalence have not changed in urban areas since 2001 but in rural areas,
there was a significant positive time trend such that by year 2008, rural prevalence was as high as in urban areas.
Conclusion: Dengue seroprevalence has stabilized but persisted at a high level in urban areas since 2001, and is
fast stabilizing in rural areas at the same high urban levels by 2008. The cumulative seroprevalence of dengue
exceeds 90 % by the age of 70 years, which translates into 16.5 million people or 55 % of the total population in
Malaysia, being infected by dengue by 2013.
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Background
Dengue is an infection caused by the arbovirus that be-
longs to the genus Flavivirus (family Flaviviridae) and
comprises four distinct, but closely related serotypes,
DENV 1,2,3 and 4 [1]. Infection with any serotype con-
fers lifelong immunity to that serotype, with partial and
temporary cross immunity to other serotypes [1, 2]. The
dengue virus is an arthropod-borne virus that is primar-
ily transmitted to humans by the Aedes aegypti and Ae-
des albopictus mosquitoes, a highly competent vector
that is well adapted to human modified environment. It
has spread extensively throughout the tropics and sub-
tropics during the past 200 years through shipping trade
routes. The spread of the vector and hence the infection
were amplified during the Second World War through
the huge increase in movement of people and equipment
aided by modern transportation [1, 3–5].
Following the Second World War, rapid expansion
and urbanization of the populations in South East Asia
(SE Asia) and other tropical countries further intensified
dengue transmission [3, 4]. Many dengue outbreaks have
been documented since the 1950s in SE Asia and this
has continued in ever larger cyclical epidemics [4]. By
2012, WHO reported that global incidence has increased
30-fold in the past 50 years and estimated that some 50
– 100 million new infections occurred annually [6]. A
recent estimate using the cartographic approach has
pushed this number up to 390 million infections a year,
more than three times WHO’s estimate and Asia bore a
disproportionate share of 70 % of the global dengue
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burden [7]. In SE Asia, recent estimates have also shown a
continuing increase in dengue incidence [8]. For example,
in Malaysia where all 4 serotypes are circulating, the most
recent estimate showed that incidence of dengue has risen
7 fold over the period between 2000 and 2010 [9]. These
estimates of the increasing dengue incidence were based
on data from dengue surveillance and cohort studies. Esti-
mating incidence based on notification data is unreliable
because of variable surveillance systems and healthcare in-
frastructures within and between countries. Besides, in
contrast to infrequent sporadic infection, for a hyper-
endemic infection like dengue which had infected more
than half of the population at any one time, and more
than 90 % of them over their lifetimes, notification of 35
million or more people over a decade or more in a typical
mid-sized population like Malaysia poses significant prac-
tical challenges. The pre-existing passive dengue surveil-
lance system is good for monitoring general trends, but
inadequate to obtain a precise number of dengue cases as
the total number of dengue cases is usually underreported
in passive surveillance. For cohort studies, obtaining a siz-
able representative sample of both children and adults na-
tionwide and following them over their lifetimes to
ascertain infection risk is no less challenging especially in
the developing countries where dengue is endemic. We
believe that repeated seroprevalence surveys using low
cost IgG enzyme-linked immunosorbant assays (ELISAs)
is the most practical and likely most reliable method to es-
timate dengue incidence in endemic countries, though
such surveys were uncommonly used in dengue epidemio-
logic research. A recent systematic review identified only
53 published seroprevalence surveys between 1980 and
2010 worldwide, and of these, only 30 surveys from 18
countries had usable IgG data and only one country had
serial sero-survey data from multiple years [10]. Sero-
prevalence data provide estimates of the proportion of
people in a population who have been previously infected
by dengue. Series of seroprevalence data over several years
also provides the basis for estimating disease incidence
based on mathematical modelling of the relationship be-
tween incidence, prevalence and mortality. This approach
has been widely used in HIV [11] and malaria [12] epi-
demiological research to estimate incidence and infection
burden in endemic countries, but to our knowledge rarely
used in the dengue research. This study aimed to compare
the urban-rural difference of dengue seroprevalence and
to determine age-specific dengue seroprevalence in
Malaysia.
Methods
This study performed trend analysis on data extracted
and compiled from published articles on dengue sero-
prevalence [13–15] and unpublished data collected from
the sentinel surveillance conducted by National Public
Health Laboratory (NPHL) of the Ministry of Health
(MOH), Malaysia [16]. All patient data were analysed
anonymously.
Ethical approval
This study was registered under National Medical Re-
search Registry (NMRR, NMRR-15-961-26546) and was
approved by Medical Research Ethics Committee, Minis-
try of Health.
Study population
Table 1 outlines the demographic characteristics for the
6 studies on dengue seroprevalence as mentioned above.
All the studies included Malaysians from all age groups
with exception of the Malaysian Cohort (TMC) study
which included adults aged between 35 and 74 years. All
studies were urban based except 2 series, Abu Bakar S.
and Lim YA (ABL) which was entirely rural and TMC
which has 40 % of its sample from rural areas.
Study by Chen et al. [14] was based at a single urban
primary care clinic where blood specimens of patients
who attended for reasons unrelated to dengue or other
febrile illnesses were collected [14]. The ABL was a rural
school and community based study. TMC study was a
nationwide, community based study of adults aged 35–
74 years living in urban and rural areas [17]. The NPHL
conducts regular sentinel surveillance based at public
health clinics located in urban areas only. In the surveil-
lance, blood specimen of patients who attended the
health clinics for reasons unrelated to dengue or other
febrile illness from the age of 1 year old onward was col-
lected (Amin F., personal communication). None of the
studies included were hospital based, nor were blood
specimens collected primarily for another purpose.
However, none of the surveys were based on a random
sample of households recruited from throughout the
country. We obtained individual level records for all the
studies except the ABL study.
We were unable to include data from two dengue vac-
cine trials conducted among Malaysian children [18, 19],
because we have no access to the data and the studies
employed a different serology method, which was
serotype-specific plaque reduction neutralisation test
(PRNT50).
Serological test
The presence of dengue IgG antibodies in sera samples
for all the seroprevalence studies was detected using the
PanBio dengue IgG indirect ELISA [13–16].
Statistical analysis
Age-specific seroprevalence rates of dengue
The age-specific seroprevalence rate was constructed
using the cubic spline method [20] by using Stata
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Version 13. The method interpolated prevalence rates
specified per five-year interval (or other irregular inter-
vals) to one-year age groups.
Poisson regression model
Poisson regression model with random effect was used
to determine time trend in dengue seroprevalence and
age dependency in the risk of dengue infection stratified
by urban or rural location. The outcome variable was
count of seroconverted subjects while each study in-
cluded was treated as random effect. The fixed effects
were calendar year, age group and urban or rural loca-
tion. The model equation is: Log (Pi) = Log(Ni) + β0 + β1
Age + β2 Year + β3 Urban-Rural (UR) location + β4Ageis*-
Year + β5Age*UR + β6 Year*i.UR + μs + εis, where Pi is the
Prevalent count of dengue of a group i, which is
cross-classified by levels of Age (8 levels) and UR lo-
cation (2 levels). Log(N) is the log transformed sam-
ple size of each Age-UR groups, β0 is a constant, β is
a slope coefficient, μs is the between survey error and
εis is the within group error.
Interactions were included in the Poisson regression
model using age-by-calendar year, calendar year-by-
location and location-by-age. We hypothesised that: 1)
when the age-by-calendar year interaction was positive
and significant, seroprevalence of dengue increased with
age and time; 2) when the calendar year-by-location
interaction was positive and significant, seroprevalence
of dengue increased over time and was dependent on
urban-rural difference; 3) when the age-by-location in-
teractions was positive and significant, seroprevalence of
dengue increased with age of subjects and was
dependent on urban-rural difference. Likelihood Ratio
test for nested models or Bayesian Information Criterion
for non-nested models was used to find the best fit for
the data. The best fitting model is used to derive the
pooled estimates of age-specific seroprevalence rates.
Results
Seroprevalence data were available for pooled sample of
11,821 subjects. The rate of seroprevalence in urban lo-
cations ranged between 61 and 92 % and in rural loca-
tions ranged between 28 and 91 %. (Table 2).
The observed crude age-specific seroprevalence de-
rived from the 6 studies were plotted as illustrated in
Fig. 1 shows cubic spline smoothed estimates of age-
specific seroprevalence for each study (TMC’s rates
below the age 35 and ABL’s rates above age 49 were
Table 1 Demographic characteristics of dengue seroprevalence studies in Malaysia
Data source aChen et al. bAbu Bakar S. and Lim YA
(ABL)
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Sample size 85 1800 1000 3762 3911 1263
Mean age (in years) 43 16 53 39 35 38
Age range (in years) 5 - 71 7 – 49 35-74 1- 93 1- 88 1- 90
Gender (%)
Female 46 No data 60 56 55 55
Male 54 No data 40 44 45 45
Ethnicity (%)
Malay 8 No data 57 48 63 40
Chinese 70 No data 37 27 15 25
Indian & others 22 No data 6 25 22 35
Geographical area (%)
Peninsular Malaysia 100 100 100 87 87 51
East Malaysia 0 0 0 13 13 49
Location (%)
Urban 100 0 60 100 100 100
Rural 0 100 40 0 0 0
aSuburban community in Puchong; bAboriginal communities throughout the countries; cNational cohort study throughout the country; d7 primary care clinics all
located at city areas in different states of Selangor, Wilayah Persekutuan Kuala Lumpur, Perak, Kelantan, Johor and Sabah
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extrapolated from available data in other age groups).
The 5 urban studies have similar seroprevalence profiles
by age. Seroprevalence rate of dengue increased with age
in both urban and rural locations. By 65 years of age, at
least 80 % of Malaysian populations from both urban
and rural locations were infected with dengue.
Using pooled data, there were no significant differ-
ences in the seroprevalence with regards to gender
(Fig. 2), ethnicity (Fig. 3) and geographical areas (Fig. 4)
across all age groups, as their 95 % CI overlapped with
each other. The age-specific rate in urban areas was
higher among the younger age of less than 40 years as
compared to those from rural locations. The age-specific
rate in urban areas was higher among the younger popu-
lation aged of less than 40 years as compared to those
from rural areas, whereas this trend is reversed by the
age of 40 years, though the 95 % confidence intervals
overlapped at the higher age range (Fig. 5).
The Poisson regression model shows a statistically sig-
nificant increase in dengue seroprevalence rates with in-
creasing age (Table 3), higher among those living in
urban locations as compared to rural locations (Fig. 6).
Table 2 Demographic characteristics and seroprevalence of dengue in Malaysia
Study Chen ABL TMC NPHL NPHL NPHL
Year 2001 2007 2008 2011 2012 2013
Sample size 85 1800 1000 3762 3911 1263
Overall crude seroprevalence (%) 77 20 92 65 61 61
Gender (%)
Male 74 No data 94 66 64 60
Female 79 No data 90 64 59 61
Ethnicity (%)
Malay 88 No data 92 56 59 55
Chinese 71 No data 91 76 68 66
Indian and others No data No data 92 68 60 64
Geographical area (%)
Peninsular Malaysia 77 20 94 65 60 57
East Malaysia No data No data No data 58 61 65
Location (%)
Urban 77 No data 92 65 61 61
Rural No data 20 91 No data No data No data
Fig. 1 Age-specific seroprevalence of dengue observed between 2000 and 2013
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When interactions were included in the model,
there is a significant difference in the time trends of
dengue seroprevalence by location (calendar year-by-
location interaction) (Table 3). While there has been
no change in dengue prevalence at all in urban loca-
tions over time, dengue prevalence at rural locations
increased over the years, showing a significant posi-
tive time trend. The age-by-location interaction is
also significant suggesting that there is in addition
an age dependent difference between urban and rural
locations. The interaction between calendar year
(time) and age is not significant (all p-values > 0.4)
indicating the age dependency in dengue seropreva-
lence has not changed over time.
Figure 6 shows the predicted age-specific dengue sero-
prevalence based on the results of the Poisson model
(Table 3). In the absence of time trend (changes over cal-
endar year), the data from predicted age-specific sero-
prevalence in urban locations for all years were pooled
and presented in a single line. On the other hand, sero-
prevalence rates in rural areas show both positive time
trend and age dependency. Thus, predicted age-specific
seroprevalence was analysed and plotted for each calen-
dar year. Only data for years 2001, 2004 and 2008 were
Fig. 2 Age-specific dengue seroprevalence estimates* by gender. Cubic spline smoothed and pooled across all surveys
Fig. 3 Age-specific dengue seroprevalence estimates* by ethnicity. Cubic spline smoothed and pooled across all surveys
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presented here to avoid crowding of Fig. 6. The slopes of
each of the 3 rural smoothened lines and the single
urban line differ from one another indicating age
dependency.
Discussion
Time trend in dengue seroprevalence
The increase in seroprevalence of dengue with age
provides a measure of dengue infection in the past.
The high seroprevalence observed since 2001
indicates a continuous high level of dengue virus ex-
posure in our population. The age-specific dengue
seroprevalence in age x is a measure of cumulative
prevalence of dengue at age x. However a single
prevalence series cannot distinguish between no
change in past dengue risk from time and/or age-
dependent change in risk of exposure. Our results,
based on multiple series observed between 2001 and
2013, showed neither a time trend nor significant age
dependency in dengue seroprevalence in urban area.
Fig. 4 Age-specific dengue seroprevalence estimates* by region. Cubic spline smoothed and pooled across all surveys
Fig. 5 Age-specific dengue seroprevalence estimates* by urban-rural location. Cubic spline smoothed and pooled across all surveys
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In other words, the dengue seroprevalence has been
uniformly high in all age groups in urban areas in
Malaysia since year 2001.
Urban-rural difference in dengue seroprevalence
Dengue is a highly transmissible urban disease on ac-
count of its mosquito vector, Aedes aegypti, which is
well adapted to urban human environments [21]. The
risk differential between urban and rural areas reported
here is expected, especially in the younger age groups.
Malaysia GDP per capita has increased 2.7 fold from
USD 4,000 to USD 11,000 between 2001 and 2014 [22].
Besides, the urban population in Malaysia has increased
from 62 % of total population in 2000 to 71 % in 2010
[23]. This rapid economic growth in the past 15 years
and the associated increasing urbanization, as well as in-
creasing population mixing enabled by the modern
transportation network in the country all might have
contributed to increasing homogeneity in dengue risk
over time between urban and rural areas and in all age
groups. Between 2001 and 2008, as shown in this study,
the prevalence of dengue in rural areas was rising fast
and converging towards the high levels observed in the
urban population. We caution however that the preva-
lence estimates reported here for rural areas are based
on only a small sample (n = 2200 out of total sample of
11,821 subjects) from 2 sero-surveys and may be unduly
sensitive to the limited data, as compared to 5 sero-
surveys for urban areas. To our knowledge, 30 sero-
surveys were conducted in 18 countries worldwide over
the past 3 decades [10], but none of them reported on
urban-rural differences to allow us to compare our re-
sults. We acknowledge that if another much larger sur-
vey had been conducted in the past in this or other
country, it may not necessary show any difference be-
tween urban and rural locations.
Table 3 Summary of regression coefficient (95 % CI and p-values) from Poisson model of dengue seroprevalence in Malaysia be-
tween 2001 and 2013
Variable Coefficient 95 % CI p-value
Age group (in year)
0–9 0 -
10–19 0 · 88 (0 · 70, 1 · 07) <0 · 0001
20–29 1 · 24 (1 · 07, 1 · 41) <0 · 0001
30–39 1 · 42 (1 · 25, 1 · 60) <0 · 0001
40–49 1 · 56 (1 · 39, 1 · 73) <0 · 0001
50–59 1 · 63 (1 · 46, 1 · 80) <0 · 0001
60–69 1 · 69 (1 · 51, 1 · 86) <0 · 0001
> 70 1 · 73 (1 · 55, 1 · 91) <0 · 0001
Location
Urban (referent) 0 - -
Rural -600.91 (-1042, -160) 0 · 0008
Calendar year -0 · 0009 - <0 · 0001
Calendar year-by-Location interaction
All years at Urban location (referent) 0 - -
All years at Rural location 0 · 30 (0 · 08, 0 · 52) 0 · 0008
Age-by-Location interaction
All ages at Urban location (referent) 0 - -
Age 0–9 at Rural location 0 - -
Age 10–19 at Rural location -0 · 07 (-0 · 49, 0 · 35) 0 · 742
Age 20–29 at Rural location 0 · 06 (-0 · 41, 0 · 54) 0 · 799
Age 30–39 at Rural location 0 · 24 (-0 · 21, 0 · 68) 0 · 294
Age 40–49 at Rural location 0 · 45 (0 · 04, 0 · 86) 0 · 031
Age 50–59 at Rural location 0 · 58 (0 · 18, 0 · 98) 0 · 004
Age 60–69 at Rural location 0 · 67 (0 · 26, 1 · 07) 0 · 001
Age >70 at Rural location 0 · 81 (0 · 40, 1 · 23) <0 · 0001
Calendar year-by-Age interaction -0 · 003 to 0 · 05 - 0 · 06 to 0 · 9
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This study has excluded data from two dengue vaccine
trials which had included Malaysian children on account
of the use of serotype-specific PRNT50 test [18, 19].
These trials have reported a very high baseline sero-
prevalence rate of 68 % among the participating children
aged 2 – 14, which is much higher than the 35 % rate in
urban children by age 14 reported in this study. This is
likely due to the use of highly sensitive PRNT50 test in
these trials. Hence, the use of the less sensitive ELISA
IgG test in the six sero-surveys included in this study
has led us to underestimate the dengue seroprevalence.
The actual seroprevalence in Malaysia was likely to be
higher than the already very high level reported here.
Dengue notification, healthcare utilization and disease
severity
There has been undoubtedly an increase in dengue notifi-
cation in the past 15 years [24]. The number notified
reached an all-time high of 108, 698 cases in 2014 (http://
idengue.remotesensing.gov.my/idengue/index.php). This
has been widely interpreted as reflecting an underlying
increasing trend in dengue incidence [8, 9] but our find-
ing of a stable but high infection risk since 2001 is not
compatible with this interpretation. Similarly the appar-
ent age shift in dengue notification rates [25], widely
interpreted as showing a shift in the risk of dengue to
older age groups, is not compatible with our finding of
uniform risk across all age groups in urban areas. We
hypothesize that this paradoxical phenomenon of in-
creasing notification and yet unchanging risk since 2001
is better explained by increasing healthcare utilization
for dengue illness. In 2014, dengue was the top reason
for hospitalization accounting for 14 % of hospital ad-
missions, and top 23rd reason for visits to primary care
clinics in Malaysia [26]. Besides the increasing availabil-
ity and wider distribution of health services, this may be
partly driven by increasing number of symptomatic and
severe cases especially in the older age groups, in con-
trast to the past observation that severe disease is pre-
dominantly seen in pediatric population [27]. This age
shift in disease severity in turn may be related to the
high persistent background dengue risk in this popula-
tion leading to higher risk of secondary infections with
prolonged exposure, which correlates with disease
severity.
Estimation of dengue incidence
The demonstration of absence of time trend and age de-
pendency in dengue risk in urban locations provides the
justification for using a single pooled age-specific sero-
prevalence rates to estimate the age-specific incidence of
dengue in urban population in Malaysia. For rural popu-
lation however, age- and year-specific estimates will be
required for the purpose. This is the subject of an on-
going work to estimate the incidence of dengue, inci-
dence of dengue notification and hospitalization, as well
as excess mortality associated with dengue illness.
Conclusions
The increasing incidence of dengue, often occurring in
cyclical epidemics, has been well documented and it is a
major public health concern in Malaysia. The trend ana-
lysis reported here showed that the risk of dengue has
stabilized but persisted at a high level in urban areas
since 2001, and is fast stabilizing in rural areas at the
same high urban levels by year 2008. In the Malaysian
population, the prevalence of infection is conservatively
estimated to exceed 90 % by the age of 70 years. This
Fig. 6 Predicted age-specific dengue seroprevalence rate using Poisson regression model by urban-rural locations
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translates into 16.5 million people, or 55 % of total Ma-
laysian population, who have previously been infected by
dengue by 2013.
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